3d investors
3d investors is a private equity and real estate investment firm based in Zwijnaarde, Belgium, established in 1992. The firm specializes in investing in middle-market companies, focusing on mature, emerging growth, industry consolidation, debt, recapitalization, buyouts, and growth capital. It targets businesses primarily in sectors such as industry, production, value-added distribution, retail, and business-to-business services, with a preference for companies located in Belgium. 3d investors typically invests between €2.5 million and €25 million in firms with an enterprise value ranging from €10 million to €100 million and target EBITDA between €2.5 million and €20 million. The firm aims to acquire majority voting shares or significant minority stakes that enable active participation in management, often taking on roles such as active chairman. In addition to private equity, 3d investors engages in real estate investments, focusing on offices, residential, and mixed-use retail properties. The firm utilizes its own capital for investments and prioritizes sustainable practices in alignment with its values.
Top Stages
1 past transactions
Univercells
Series D in 2022
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.